Cargando…
A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease models
One of the pathways of the unfolded protein response, initiated by PKR-like endoplasmic reticulum kinase (PERK), is key to neuronal homeostasis in neurodegenerative diseases. PERK pathway activation is usually accomplished by inhibiting eIF2α-P dephosphorylation, after its phosphorylation by PERK. L...
Autores principales: | Ganz, Javier, Shacham, Talya, Kramer, Maria, Shenkman, Marina, Eiger, Hagit, Weinberg, Nitai, Iancovici, Ori, Roy, Somnath, Simhaev, Luba, Da’adoosh, Benny, Engel, Hamutal, Perets, Nisim, Barhum, Yael, Portnoy, Moshe, Offen, Daniel, Lederkremer, Gerardo Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181660/ https://www.ncbi.nlm.nih.gov/pubmed/32327686 http://dx.doi.org/10.1038/s41598-020-63899-4 |
Ejemplares similares
-
PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?
por: Shacham, Talya, et al.
Publicado: (2021) -
Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model
por: Fellner, Avi, et al.
Publicado: (2017) -
Protein Misfolding and ER Stress in Huntington's Disease
por: Shacham, Talya, et al.
Publicado: (2019) -
Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice
por: Perets, Nisim, et al.
Publicado: (2018) -
Computational design of substrate selective inhibition
por: Da’adoosh, Benny, et al.
Publicado: (2020)